Particle.news
Download on the App Store

Ebola Outbreak in Eastern DRC Surpasses 2,000 Confirmed Deaths

The fast-moving Bundibugyo variant is outpacing response teams and has no approved vaccine or treatment.

Overview

  • Genetic analyses indicate the virus circulated for months before detection, allowing the outbreak to seed widely in remote areas of eastern and northeastern provinces.
  • DRC health data published between Aug. 9 and Aug. 13 show roughly 2,000 to 2,128 confirmed deaths and about 4,381 to 4,566 confirmed cases, making this one of the deadliest Ebola episodes recorded.
  • The epidemic is driven by the Bundibugyo variant, for which there are no licensed vaccines or treatments, complicating standard containment measures such as ring vaccination and targeted therapeutics.
  • Response teams are reaching only about one-third of cases and estimate 60–70% of deaths occur in communities that receive no assistance because conflict, weak surveillance, health worker payment problems and community distrust block access.
  • WHO and Gavi have recommended and are preparing phase‑3 evaluation of the licensed Ervebo vaccine with doses from the global stockpile to support trials, and the WHO projects a possible peak in roughly six months with a worse-case duration of nine to twelve months while routine child health services already show serious collapse.